Treatment outcomes of an integrated residential programme for patients with schizophrenia and substance use disorder

European Addiction Research

Volumn 17, Issue 3, 2011, Pages 154-163

  Morrens, Manuel ^a,b,c   Dewilde, Bieke ^a,d   Sabbe, Bernard ^a,e   Dom, Geert ^a,c   De Cuyper, Raoul ^f   Moggi, Franz ^g,h  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Psychiatric Hospital GGZWNB   (Netherlands)

^c Psychiatric Centre Broeders Alexianen   (Belgium)

^d Stuivenberg General Hospital   (Belgium)

^e Psychiatric Centre St Norbertushuis   (Belgium)

^f Psychiatric Centre Sleidinge   (Belgium)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Addiction; Community functioning; Dual diagnosis; Quality of life; Schizophrenia; Substance use disorder

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; OPIATE; PSYCHEDELIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; COMMUNITY PROGRAM; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GROUP THERAPY; HUMAN; INTEGRATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OPIATE ADDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL STATUS; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; RESIDENTIAL TREATMENT; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953031720     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324480     Document Type: Article

References (51)

1. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991; 148: 224-230.
2. Fowler IL, Carr VJ, Carter NT, Lewin TJ: Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443-455. (Pubitemid 28378229)
3. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD: Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract 2005; 11: 315-339. (Pubitemid 41540226)
4. Blanchard JJ, Brown SA, Horan WP, Sherwood AR: Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000; 20: 207-234. (Pubitemid 30100433)
5. Ries RK, Russo J, Wingerson D, Snowden M, Comtois KA, Srebnik D, Roy-Byrne P: Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psychiatr Serv 2000; 51: 210-215. (Pubitemid 30082524)
6. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB: Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996; 20: 145-151. (Pubitemid 26387512)
7. Cantwell R, Scottish Comorbidity Study Group: Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br J Psychiatry 2003; 182: 324-329. (Pubitemid 36408284)
8. Caton CL, Shrout PE, Eagle PF, Opler LA, Felix A: Correlates of codisorders in homeless and never homeless indigent schizophrenic men. Psychol Med 1994; 24: 681-688. (Pubitemid 24265751)
9. Dixon L, McNary S, Lehman A: Substance abuse and family relationships of persons with severe mental illness. Am J Psychiatry 1995; 152: 456-458.
10. Xie H, McHugo GJ, Helmstetter BS, Drake RE: Three-year recovery outcomes for longterm patients with co-occurring schizophrenic and substance use disorders. Schizophr Res 2005; 75: 337-348. (Pubitemid 40693066)
11. Ouimette PC, Ahrens C, Moos RH, Finney JW: During treatment changes in substance abuse patients with posttraumatic stress disorder. The influence of specific interventions and program environments. J Subst Abuse Treat 1998; 15: 555-564. (Pubitemid 28559453)
12. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR: Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589-608. (Pubitemid 28524628)
13. Drake RE, Mueser KT: Psychosocial approaches to dual diagnosis. Schizophr Bull 1993; 26: 105-118.
14. Tsuang J, Fong TW: Treatment of patients with schizophrenia and substance abuse disorders. Curr Pharm Des 2004; 10: 2249-2261. (Pubitemid 38832767)
15. Ziedonis DM: Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr 2004; 9: 892-904, 925.
16. Tiet QQ, Mausbach B: Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 2007; 31: 513-536. (Pubitemid 46434889)
17. Cleary M, Hunt G, Matheson S, Siegfried N, Walter G: Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008; 1:CD001088.
18. Kofoed L, Kania J, Walsh T, Atkinson RM: Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders. Am J Psychiatry 1986; 143: 867-872. (Pubitemid 16090392)
19. Hellerstein D, Meehan B: Outpatient group therapy for schizophrenic substance abusers. Am J Psychiatry 1987; 144: 1337-1340.
20. Hellerstein DJ, Rosenthal RN, Miner CR: A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients. Am J Addict 1995; 4: 33-42.
21. Ziedonis DM, Trudeau K: Motivation to quit using substances among individuals with schizophrenia: implications for a motivation- based treatment model. Schizophr Bull 1997; 23: 229-238. (Pubitemid 27224875)
22. Blankertz LE, Cnaan RA: Assessing the impact of two residential programs for dually diagnosed homeless individuals. Soc Serv Rev 1994; 68: 536-560.
23. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ: Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis 1997; 185: 298-305. (Pubitemid 27244253)
24. Herman SE, Frank KA, Mowbray CT, Ribisl KM, Davidson WS, BootsMiller B, Jordan L, Greenfield AL, Loveland D, Luke DA: Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. J Behav Health Serv Res 2000; 27: 286-302. (Pubitemid 30485796)
25. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM: A 'community-friendly' version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend 2009; 104: 212-219.
26. Hides L, Carroll S, Catania L, Cotton SM, Baker A, Scaffidi A, Lubman DI: Outcomes of an integrated cognitive behaviour therapy treatment program for co-occurring depression and substance misuse in young people. J Affect Disord 2010; 121: 169-174.
27. Moggi F, Brodbeck J, Költzsch K, Hirsbrunner HP, Bachmann KM: One-year followup of dual diagnosis patients attending a 4-month integrated inpatient treatment. Eur Addict Res 2002; 8: 30-37. (Pubitemid 34701982)
28. Moggi F, Hirsbrunner HP, Brodbeck J, Bachmann KM: One-year outcome of an integrative inpatient treatment for dual diagnosis patients. Addict Behav 1999; 24: 589-592. (Pubitemid 29342938)
29. Bartels SJ, Drake RE: A pilot study of residential treatment for dual diagnosis. J Nerv Ment Dis 1996; 184: 379-381. (Pubitemid 26227812)
30. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R: Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001; 158: 1706-1713. (Pubitemid 32923666)
31. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N: Cognitivebehavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial. Br J Psychiatry 2003; 183: 418-426. (Pubitemid 37357574)
32. Burnam MA, Morton SC, McGlynn EA, Petersen LP, Stecher BM, Hayes C, Vaccaro JV: An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. J Addict Dis 1995; 14: 111-134. (Pubitemid 26059735)
33. Nigam R, Schottenfeld R, Kosten TR: Treatment of dual diagnosis patients: a relapse prevention group approach. J Subst Abuse Treat 1992; 9: 305-309. (Pubitemid 23052626)
34. Ries RK, Ellingson T: A pilot assessment at one month of 17 dual diagnosis patients. Hosp Community Psychiatry 1990; 41: 1230-1233. (Pubitemid 20368361)
35. Craig TK, Johnson S, McCrone P, Afuwape S, Hughes E, Gournay K, White I, Wanigaratne S, Leese M, Thornicroft G: Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months. Psychiatr Serv 2008; 59: 276-282.
36. Bartels SJ, Drake RE, Wallach MA: Longterm course of substance use disorders among patients with severe mental illness. Psychiatr Serv 1995; 46: 248-251.
37. Drake RE, Bartels, SB, Teague GB, Noordsy DL, Clark RE: Treatment of substance use disorders in severely mentally ill patients. J Nerv Ment Dis 1993; 181: 606-611. (Pubitemid 24259649)
38. Durell J, Lechtenberg B, Corse S, Frances RJ: Intensive case management of persons with chronic mental illness who abuse substances. Hosp Community Psychiatry 1993; 44: 415-416, 428.
39. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 rev. Washington, APA, 2000.
40. Drake RE, Mueser KT, Brunette MF, McHugo GJ: A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 2004; 27: 360-374. (Pubitemid 38750183)
41. McLellan AT, Luborsky L, Woody GE, O'Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 826-833.
42. Drake RE, Mueser KT, McHugo GJ: Clinician Rating Scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SATS); in Sederer LI, Dickey B (eds): Outcomes Assessment in Clinical Practice. Baltimore, Williams & Wilkins, 1996, pp 113-116.
43. Kay SR, Fiszbein A, Opler LE: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-275.
44. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Fitzpatrick R, Jenkinson C: Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 2000; 177: 42-46. (Pubitemid 30450663)
45. Hesse M: Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009; 9: 6.
46. Grella CE, Stein JA, Weisner C, Chi F, Moos R: Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems. Drug Alcohol Depend 2010; 110: 92-100.
47. Shaner A, Eckman T, Roberts LJ, Fuller T: Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatr Serv 2003; 54: 1287-1289. (Pubitemid 37055993)
48. Godley SH, Hoewing-Roberson R, Godley MD: Final MISA Report. Bloomington, Lighthouse Institute, 1994.
49. Detrick A, Stiepock V: Treating persons with mental illness, substance abuse, and legal problems: The Rhode Island experience; in Stein LI (ed): Innovative Community Mental Health Programs. New Directions for Mental Health Services. San Francisco, Jossey- Bass, 1992, vol 56, pp 65-77.
50. Jerrell JM, Ridgely MS: Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. J Nerv Ment Dis 1995; 183: 566-576.
51. Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N: Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ 2010; 341:c6325.